Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Maritz, MF"'
Autor:
Elsemary MT; Future Industries Institute, University of South Australia Mawson Lakes Campus, Mawson Lakes, SA, Australia., Maritz MF; Future Industries Institute, University of South Australia Mawson Lakes Campus, Mawson Lakes, SA, Australia., Smith LE; Future Industries Institute, University of South Australia Mawson Lakes Campus, Mawson Lakes, SA, Australia., Warkiani ME; University of Technology Sydney, Ultimo, NSW, Australia., Thierry B; Future Industries Institute, University of South Australia Mawson Lakes Campus, Mawson Lakes, SA, Australia. Electronic address: benjamin.thierry@unisa.edu.au.
Publikováno v:
Cytotherapy [Cytotherapy] 2024 Oct; Vol. 26 (10), pp. 1264-1274. Date of Electronic Publication: 2024 May 10.
Autor:
Rodseth E; Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa., Sumasgutner P; FitzPatrick Institute of African Ornithology, University of Cape Town, Cape Town, South Africa.; Konrad Lorenz Research Centre, Department of Behavioural and Cognitive Biology, University of Vienna, Vienna, Austria., Tate G; FitzPatrick Institute of African Ornithology, University of Cape Town, Cape Town, South Africa.; Birds of Prey Programme, Endangered Wildlife Trust, Midrand, South Africa., Nilsson JF; Evolutionary Ecology, Department of Biology, Lund University, Lund, Sweden., Watson H; Evolutionary Ecology, Department of Biology, Lund University, Lund, Sweden., Maritz MF; Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa., Ingle RA; Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa., Amar A; FitzPatrick Institute of African Ornithology, University of Cape Town, Cape Town, South Africa.
Publikováno v:
Royal Society open science [R Soc Open Sci] 2024 Apr 03; Vol. 11 (4), pp. 230370. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).
Autor:
Badiee P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology University of South Australia Adelaide Australia.; UniSA Clinical and Health Sciences University of South Australia Adelaide Australia., Maritz MF; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology University of South Australia Adelaide Australia., Dehghankelishadi P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology University of South Australia Adelaide Australia.; UniSA Clinical and Health Sciences University of South Australia Adelaide Australia., Dmochowska N; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology University of South Australia Adelaide Australia., Thierry B; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology University of South Australia Adelaide Australia.
Publikováno v:
Bioengineering & translational medicine [Bioeng Transl Med] 2023 Oct 28; Vol. 9 (1), pp. e10599. Date of Electronic Publication: 2023 Oct 28 (Print Publication: 2024).
Autor:
Elsemary, MT, Maritz, MF, Smith, LE, Warkiani, M, Bandara, V, Napoli, S, Barry, SC, Coombs, JT, Thierry, B
Chimeric antigen receptor T (CAR-T) cell therapy is rapidly becoming a frontline cancer therapy. However, the manufacturing process is time-, labor- and cost-intensive, and it suffers from significant bottlenecks. Many CAR-T products fail to reach th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::a9b9d4752ba59f275788c083a343e08d
https://hdl.handle.net/10453/169052
https://hdl.handle.net/10453/169052
Autor:
Dehghankelishadi P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA, 5095, Australia.; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA, 5000, Australia., Badiee P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA, 5095, Australia.; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA, 5000, Australia., Maritz MF; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA, 5095, Australia., Dmochowska N; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA, 5095, Australia., Thierry B; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA, 5095, Australia. benjamin.thierry@unisa.edu.au.; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA, 5000, Australia. benjamin.thierry@unisa.edu.au.
Publikováno v:
Journal of nanobiotechnology [J Nanobiotechnology] 2023 Mar 21; Vol. 21 (1), pp. 102. Date of Electronic Publication: 2023 Mar 21.
Autor:
Guo, Z, Yang, CT, Maritz, MF, Wu, H, Wilson, P, Warkiani, ME, Chien, CC, Kempson, I, Aref, AR, Thierry, B
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim The therapeutic ratio of radiotherapy is limited by acute or chronic side effects with often severe consequences to patients. The microvasculature is a central player involved in both tumor responses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::751e09ae4728cc20fce871a2ecf1cdcb
https://hdl.handle.net/10453/139174
https://hdl.handle.net/10453/139174
Autor:
Badiee P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia., Maritz MF; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia., Thierry B; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia. Electronic address: benjamin.thierry@unisa.edu.au.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2022 Jun 25; Vol. 622, pp. 121845. Date of Electronic Publication: 2022 May 22.
Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.
Autor:
Dehghankelishadi P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia., Maritz MF; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia., Dmochowska N; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia., Badiee P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia., Cheah E; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia., Kempson I; Future Industries Institute, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia., Berbeco RI; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Thierry B; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia. Electronic address: benjamin.thierry@unisa.edu.au.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Jun; Vol. 346, pp. 98-109. Date of Electronic Publication: 2022 Apr 21.
Autor:
Badiee P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia.; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia., Maritz MF; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia., Dmochowska N; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia., Cheah E; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia.; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia., Thierry B; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia.; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia.
Publikováno v:
ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2022 Apr 13; Vol. 14 (14), pp. 15881-15893. Date of Electronic Publication: 2022 Mar 31.
Autor:
Dehghankelishadi P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia., Maritz MF; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia., Badiee P; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia., Thierry B; Future Industries Institute and ARC Centre of Excellence Convergent Bio-Nano Science and Technology, University of South Australia, Mawson Lakes Campus, Adelaide, SA 5095, Australia; UniSA Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, SA 5000, Australia. Electronic address: benjamin.thierry@unisa.edu.au.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2022 Apr 05; Vol. 617, pp. 121585. Date of Electronic Publication: 2022 Feb 15.